Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • DNA signature in Ice Storm babies: Prenatal maternal stress exposure to natural disasters predicts epigenetic profile of offspring

  • Chefs at schools can increase school meal participation, vegetable intake among students

  • Improving babies' language skills before they're even old enough to speak

  • After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

  • How career dreams are born

  • Who are the men, boys suffering from anorexia?

  • Feeling fatigued while driving? Don't reach for your music

  • New clues revealed to understand brain stimulation

  • What makes a song sing? Backup singers

  • Transplant drug could boost power of brain tumor treatments, study finds

  •